Xuefei Shou

1.9k citations
51 papers · 669 indexed · h-index 14
Topics
Pituitary Gland Disorders and Treatments (43 papers)Growth Hormone and Insulin-like Growth Factors (24 papers)Glioma Diagnosis and Treatment (13 papers)
Partner nations
ChinaUnited States

In The Last Decade

Xuefei Shou

48 papers receiving 663 citations

Peers

Xuefei Shou
Comparison fields: 5 of 57
  • Endocrinology, Diabetes and Metabolism 554
  • Surgery 281
  • Epidemiology 221
  • Genetics 121
  • Molecular Biology 51
Replace Shahzada Ahmed with:
Shahzada Ahmed United Kingdom
R. Oeckler Germany
Martha Lilia Tena‐Suck Mexico
P. Thierauf Germany
Abdulrahman Albakr Saudi Arabia
Kazuhito Takeuchi Japan
Stefan Linsler Germany
Bertrand Baussart France
Mindy Rabinowitz United States
Pedro Riesgo Spain
Xuefei Shou relative to Shahzada Ahmed United Kingdom Shahzada Ahmed's profile →
Citations per field
00.5×5.3×
Shahzada Ahmed · 1×
Citations per year

Countries citing papers authored by Xuefei Shou

Since Specialization
Citations

This map shows the geographic impact of Xuefei Shou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefei Shou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefei Shou more than expected).

Fields of papers citing papers by Xuefei Shou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefei Shou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefei Shou. The network helps show where Xuefei Shou may publish in the future.

Co-authorship network of co-authors of Xuefei Shou

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefei Shou. A scholar is included among the top collaborators of Xuefei Shou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefei Shou. Xuefei Shou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 1
3 3
4 9
5 0
6 6
7 7
8 10
9 13
10 13
11 9
12 16
13 34
14 6
15 2
16 9
17 9
18 18
19 58
20 11

About Xuefei Shou

Xuefei Shou is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Ophthalmology, having authored 51 papers that have together received 669 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (43 papers), Growth Hormone and Insulin-like Growth Factors (24 papers) and Glioma Diagnosis and Treatment (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (554 citations), Genetics (121 citations) and Epidemiology (221 citations). Xuefei Shou has collaborated with scholars based in China and United States. Frequent co-authors include Shiqi Li, Yao Zhao, Yongfei Wang, Ming Shen, Nidan Qiao, Yongfei Wang, Zhaoyun Zhang, Jinsong Wu, Wenqiang He and Ying Mao. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026